- Donanemab in Early Alzheimer’s Disease nejm.org
- New Drug Shows Promise for Slowing Cognitive Decline in Alzheimer’s Patients Interesting Engineering
- Novel Alzheimer’s Drug Slows Cognitive Decline in Phase 2 Trial Medscape
- Eli Lilly reports mixed data on Alzheimer’s drug donanemab Business Insider
- Lilly Presents Trial Data on Alzheimer Drug Showing Promise Bloomberg
- View Full coverage on Google News